In a report published Tuesday, Stifel analyst Steve Rubis initiated coverage on athenahealth ATHN with a Buy rating and $155.00 price target.
In the report, Stifel noted, “We are initiating coverage of athenahealth, Inc., with a Buy rating on the shares and a $155.00 12-month target price. Our target equates to an enterprise value multiple of 6.7x our 2015 revenue estimate of $920.5 million. We believe athenahealth represents a cornerstone franchise within the digital healthcare industry. Through cloud-based software, networked knowledge, and value-add back-office administration, the company aims to be the caregiver's most trusted service platform.”
athenahealth closed on Monday at $124.50.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in